Liposomal doxorubicin stealth vs. carboplatin/paclitaxel in recurrent ovarian cancer patients with platinum-free interval between 6-12 months
Trial Number
NCT00657878 (ClinicalTrials.gov Identifier)Contact Person
Status
Completed
Disease Site
Recurrent Ovarian
Lead Cooperative Group
Participating Groups
MaNGO
BGOG
AGO